Summary
RBC 2,3-DPG resulted statistically increased versus normal subjects in 22 insulin-dependent diabetics affected by arterial vasculopathy and in 19 vasculopathic non-diabetic patients. RBC 2,3-DPG, on the other hand, did not differ from the normal mean in 16 insulin-dependent diabetics without vascular involvement. The increase of RBC 2,3-DPG represents principally a consequence of the vasculopathy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alberti K. G. M. M., Emerson P. M., Darley J. H., Hockaday T. D. R.: Red cell 2,3-diphosphoglycerate and diabetes — Lancet1, 843, 1972.
Alberti K. G. M. M., Emerson P. M., Darley J. H., Hockaday T. D. R.: 2,3-diphosphoglycerate and tissue oxygenation in uncontrolled diabetes mellitus — Lancet2, 391, 1972.
Andersen H., Ditzel J.: Importance of plasma inorganic phosphate in the treatment of diabetic ketoacidosis — Diabetes22 (Suppl. 1), 293, 1973.
Benesch R., Benesch R. E.: The effect of organic phosphates from human erythrocytes on the allosteric properties of hemoglobin — Biochem. biophys. Res. Commun.26, 162, 1967.
Chanutin A., Curnis R. R.: Effect of organic and inorganic phosphates on oxygen equilibrium of human erythrocytes — Arch. Biochem.121, 96, 1967.
Ditzel J.: Impaired oxygen release caused by alterations of the metabolism in the erythrocytes in diabetes — Lancet1, 721, 1972.
Ditzel J.: Adaptive changes to tissue hypoxia in ambulatory juvenile diabetics — Diabetes22 (Suppl. 1), 317, 1973.
Ditzel J., Andersen H., Daugaard Peters N.: Increased haemoglobin A1c and 2,3-diphosphoglycerate in diabetes and their effects on red-cell oxygen-releasing capacity — Lancet2, 1034, 1973.
Ditzel J., Daugaard Peters N., Andersen H.: Oxygen affinity of haemoglobin and red cell-2,3-DPG in childhood diabetes — Diabetologia10, 363, 1974.
Ditzel J., Jaeger P., Standl E.: Haemoglobin A1c, red cell 2,3-diphosphoglycerate and haemoglobin-oxygen affinity before and after insulin in newly diagnosed diabetics — Diabetologia13, 390, 1977.
Hockaday T. D. R., Alberti K. G. M. M.: Oxygen delivery to the tissue — Clin. Endocr. Metab.1, 768, 1972.
Kanter Y., Bessman S., Bessman A. N.: Red cell 2,3-diphosphoglycerate levels among diabetic patients with and without vascular complications — Diabetes24, 724, 1975.
Kanter Y., Gerson J. R., Bessman A. N.: 2,3-Diphosphoglycerate, nucleotide phosphate and organic and inorganic phosphate levels during the early phases of diabetic ketoacidosis — Diabetes26, 429, 1977.
Lowry O. H., Passonneau J. V., Hasselberger F. X., Schulz D. W.: Effect of ischemia on known substrates and cofactors of the glycolytic pathway in brain — J. biol. Chem.239, 18, 1964.
Nevis M. A.: Oxyhemoglobin equilibrium in ischemic heart disease — J. Amer. med. Ass.229, 804, 1974.
Oski F. A., Gottlieb A. J., Delivoira-Papadopoulos M., Miller W. W.: Red cell diphosphoglycerate levels in subjects with chronic hypoxemia — New Engl. J. Med.280, 1165, 1969.
Rorth M., Parving H. H., Munkgaard S.: Red cell oxygen affinity and 2,3-diphosphoglycerate in diabetes — Lancet1, 1179, 1972.
Torrance J., Jacobs P., Restrepo A., Eschbach J., Lenfant C. A.: Intraerythrocytic adaptation to anemia — New Engl. J. Med.283, 165, 1970.
Valeri C. R., Fortier N. L.: Red cell 2,3-diphosphoglycerate and creatinine levels in patients with red cell mass deficits or with cardiopulmonary insufficiency — New Engl. J. Med.281, 1452, 1969.
Woodson R. D., Torrance J. D., Shappell S. D., Lenfant C.: The effect of cardiac disease on hemoglobin-oxygen binding — J. clin. Invest.49, 1349, 1970.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Puxeddu, A., Brunetti, P., Calabrese, G. et al. Red cell 2,3-DPG levels in diabetic vasculopathy. Acta diabet. lat 16, 311–315 (1979). https://doi.org/10.1007/BF02587652
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02587652